Guru Ownership Over Time
Guru Analysis for Fate Therapeutics, Inc. (FATE)
Fate Therapeutics, Inc. (FATE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.5 M.
Top institutional holders include Renaissance Technologies and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $2.06 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies who increased their stake by 488.7%.
| Portfolio Manager | % of portfolio | Activity | Shares | Value | Peroid |
|---|---|---|---|---|---|
| 0.00% | Add 488.7% | 1,262,515 | $1.59 M | Q3 2025 | |
| 0.00% | Add 33.7% | 1,131,414 | $1.43 M | Q3 2025 | |
| 0.28% | Add 69.9% | 729,188 | $918,777 | Q3 2025 |
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Portfolio Manager | Option Type | % of portfolio | Activity | Shares | Value | Period |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown(Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Fate Therapeutics, Inc. (FATE)
Top Guru holders include Renaissance Technologies ($1.59 M), Cliff Asness ($1.43 M), Robert Bruce ($918,777). Collectively, tracked Gurus hold 3.12 M shares.
Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $2.06 M, with 3 Gurus buying and 0 Gurus selling.
No tracked Gurus reduced or sold out of their positions in FATE during the most recent reported quarter.
Yes, 0 Gurus opened new positions in FATE, and 3 added to their existing holdings. Total buy value was $2.06 M.